Cannabinoid receptors and the cytokine network

Advances in Experimental Medicine and Biology

Volumn 437, Issue , 1998, Pages 215-222

  Klein, Thomas W ^a   Newton, Catherine ^a   Friedman, Herman ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CYTOKINE; DRONABINOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; JWH 051; PERTUSSIS TOXIN; POKEWEED MITOGEN; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; IMMUNOMODULATION; INFECTION RESISTANCE; LEGIONELLA PNEUMOPHILA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALIA; LEGIONELLA PNEUMOPHILA; PHYTOLACCACEAE;

EID: 0031823348     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5347-2_24     Document Type: Conference Paper

References (18)

1. Klein, T., Friedman, H. and Specter, S., Marijuana, immunity, and infection, J. Neuroimmunol., in press, (1998).
2. Mechoulam, R., Hanus, L. and B.R., M., Search for endogenous ligands of the cannabinoid receptor., Biochem. Pharmacol., 48:1537, (1994).
3. Schatz, A.R., Lee, M., Condie, R.B., Pulaski, J.T. and Kaminski, N.E., Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system., Toxicol. appl. Pharm., 142:278, (1997).
4. Derocq, J., Segui, M., Marchand, J., LeFur, G. and Casellas, P., Cannabinoids enhance human B-cell growth at low nanomolar concentrations., FEBS Letters, 369:177, (1995).
5. Daaka, Y., Friedman, H. and Klein, T.W., Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation., J. Pharmacol. Exp. Ther., 276:776, (1996).
6. 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila., J. Pharmacol. Exp. Ther., 267:635, (1993).
7. Newton, C.A., Klein, T.W. and Friedman, H., Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta- 9-tetrahydrocannabinol injection., Infect. Immun., 62:4015, (1994).
8. Kaminski, N.E., Abood, M.E., Kessler, F.K., Martin, B.R. and Schatz, A.R., Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid- mediated immune modulation., Mol. Pharm., 42:736, (1992).
9. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J.C. and LeFur, G., SR141716A, a potent and selective antagonist of the brain cannabinoid receptor., FEBS Letters, 350:240, (1994).
10. Bayewitch, M., Avidor-Reiss, T., Levy, R., Barg, J., Mechoulam, R. and Vogel, Z., The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling., FEBS Letters, 375:143, (1995).
11. Felder, C.C., Joyce, K.E., Briley, E.M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A.L. and Mitchell, R.L., Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors., Mol. Pharmacol., 48:443, (1995).
12. Compton, D.R., Rice, K.C., De Costa, B.R., Razdan, R.K., Melvin, L.S., Johnson, M.R. and Martin, B.R., Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities., J. Pharmacol. Exp. Ther., 265:218, (1993).
13. Shire, D., Calandra, B., Rinaldi-Carmona, M., Oustric, D., Pessegue, B., Bonnin-Cabanne, O., Le Fur, G., Caput, D. and Ferrara, P., Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor., Biochim. Biophys. Acta, 1307:132, (1996).
14. Huffman, J.W., Yu, S., Showalter, V., Abood, M.E., Wiley, J.L., Compton, D.R., Martin, B.R., Bramblett, R.D. and Reggio, P.H., Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor., J. Med. Chem., 39:3875, (1996).
15. Allen, J.E. and Maizels, R.M., Th1-Th2: reliable paradigm or dangerous dogma?, Immunol. Today, 18:387, (1997).
16. Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., Maffrand, J., Le Fur, G. and Casellas, P., A selective inverse agonist for central cannabinoid receptor inhibits mitoge-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1., J. Biol. Chem., 272:22330, (1997).
17. Galieque, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G. and Casellas, P., Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations., Eur. J. Biochem., 232:54, (1995).
18. Munro, S., Thomas, K.L. and Abu-Shaar, M., Molecular characterization of a peripheral receptor for cannabinoids., Nature, 365:61, (1993).